Zsolt Cselényi Selected Research

Protein Kinases (Protein Kinase)

12/2021

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zsolt Cselényi Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2009
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2015
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2003 - 08/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2015 - 04/2008
2	Neuroinflammatory Diseases 09/2015 - 06/2011
1	Cognitive Dysfunction 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Synucleinopathies 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2021
1	Neoplasms (Cancer) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Mood Disorders (Mood Disorder) 05/2015
1	Anxiety Disorders (Anxiety Disorder) 11/2013
1	Mania (Manias) 11/2013
1	Major Depressive Disorder (Major Depressive Disorders) 11/2013
1	Schizophrenia (Dementia Praecox) 11/2013
1	Dementia (Dementias) 06/2013
1	Prodromal Symptoms 04/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2008
1	Sclerosis 01/2008
1	Multiple Sclerosis 01/2008
1	Restless Legs Syndrome (Restless Legs) 08/2006
1	Stroke (Strokes) 11/2002

Drug/Important Bio-Agent (IBA)

5	Amyloid (Amyloid Fibrils)IBA 01/2024 - 11/2009
5	vinpocetineIBA 06/2011 - 08/2002
3	2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA 01/2024 - 11/2009
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
2	osimertinibIBA 01/2023 - 01/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2015
2	Amyloid beta-PeptidesIBA 09/2015 - 10/2010
2	Neuroprotective AgentsIBA 11/2003 - 08/2002
1	5-HT1A Serotonin ReceptorIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	AZD1390IBA 12/2021
1	AZD9272IBA 01/2020
1	Metabotropic Glutamate 5 ReceptorIBA 01/2020
1	fenobamIBA 01/2020
1	LigandsIBA 01/2020
1	Monoamine Oxidase (MAO)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 09/2015
1	AZD3241IBA 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	Serotonin (5 Hydroxytryptamine)IBA 05/2015
1	Quetiapine Fumarate (Seroquel)FDA Link 11/2013
1	Antipsychotic Agents (Antipsychotics)IBA 11/2013
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 06/2013
1	AZD2995IBA 04/2013
1	PK 11195 (PK11195)IBA 01/2008
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 12/2021
1	Aftercare (After-Treatment) 09/2015
1	Therapeutics 04/2013
1	Oral Administration 08/2002